616450 Sigma-AldrichTGF-β1, Human Platelets
Productos recomendados
Descripción
Replacement Information |
---|
Tabla espec. clave
Purity |
---|
≥97% by SDS-PAGE |
Product Information | |
---|---|
Form | Lyophilized |
Formulation | Lyophilized from a sterile-filtered solution of 50 µg BSA/µg TGF-β1, 35% acetonitrile, 0.1% TFA. |
Quality Level | MQ100 |
Applications |
---|
Physicochemical Information | |
---|---|
Contaminants | Endotoxin: ≤1 EU/ug of TGF-β1 |
Dimensions |
---|
Materials Information |
---|
Toxicological Information |
---|
Safety Information according to GHS |
---|
Safety Information |
---|
Product Usage Statements |
---|
Packaging Information |
---|
Transport Information |
---|
Supplemental Information |
---|
Specifications |
---|
Global Trade Item Number | |
---|---|
Número de referencia | GTIN |
616450 | 0 |
Documentation
Licencias necesarias
Título |
---|
PRODUCTO REGULADO POR LA SECRETARÍA DE SALUD |
TGF-β1, Human Platelets Ficha datos de seguridad (MSDS)
Título |
---|
TGF-β1, Human Platelets Certificados de análisis
Cargo | Número de lote |
---|---|
616450 |
Referencias bibliográficas
Visión general referencias |
---|
Lomo, J., et al. 1995. J. Immunol. 154, 1634. Marushige, K. and Marushige, Y. 1995. Anticancer Res. 14, 2419. Bermundez, L.E. 1993. J. Immunol. 150, 1838. Hamilton, J.A., et al. 1993. J. Immunol. 150, 1496. Reilly, J.T., et al. 1993. Br. J. Haematol. 83, 58. Sporn, M.B. and Roberts, A.B. 1993. Growth Factors 8, 1. |